fluvoxamine

(redirected from Fluvoxamine maleate)
Also found in: Medical.

flu·vox·a·mine

 (flo͞o-vŏk′sə-mēn′)
n.
A drug of the SSRI class, C15H21O2N2F3, used in its maleate form primarily to treat obsessive-compulsive disorder.

[flu(oro)- + valero-, containing valeric acid + ox(y)- + amine.]

fluvoxamine

(fluːˈvɒksəmiːn)
n
(Pharmacology) an antidepressant drug that acts by preventing the re-uptake after release of serotonin in the brain, thereby prolonging its action. See SSRI
Mentioned in ?
References in periodicals archive ?
The project was carried out to measure fluvoxamine maleate drug by using a modified electrode with high sensitivity in biological samples.
The average age of the patients was 33 years, and their medications included sertraline, fluoxetine, paroxetine, citalopram, escitalopram oxalate, and fluvoxamine maleate.
Tokyo, Japan, Oct 15, 2005 - (JCNN) - Meiji Seika Kaisha and Solvay Seiyaku jointly announced on October 12 that they have obtained approval of additional indication for fluvoxamine maleate from the Ministry of Health, Labor and Welfare as of October 11.
Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for fluvoxamine maleate 100 mg and 150 mg extended-release (ER) capsules.
LUVOX CR Capsules are also contraindicated in patients with a history of hypersensitivity to fluvoxamine maleate or any of its excipients.
announced today a product license agreement under which Jazz Pharmaceuticals will have the right to market LUVOX([R]) (fluvoxamine maleate) Tablets and fluvoxamine maleate extended-release capsules, upon approval by the Food and Drug Administration (FDA), in the United States.
announced that the Food and Drug Administration approved Synthon's abbreviated new drug application (ANDA) on January 17 for fluvoxamine maleate tablets in 25 mg, 50 mg and 100 mg strengths.